IONSYS (fentanyl), analgesic
NEUROLOGY - New presentation
Opinions on drugs -
Posted on
Feb 02 2017
Reason for request
Inclusion
No clinical benefit demonstrated when compared with intravenous patient-controlled analgesia, in the treatment of acute moderate to severe post-operative pain in adult patients
- IONSYS has Marketing Authorisation in the treatment of acute moderate to severe post-operative pain in adult patients.
- The administration device of IONSYS involves electrically assisted transdermal iontophoresis. No benefit has been demonstrated by comparison with intravenous, patient-controlled analgesia.
Clinical Benefit
Substantial |
- |
Clinical Added Value
no clinical added value |
- |
Therapeutic use
- |
English version
Contact Us
Évaluation des médicaments